Compounded semaglutide and tirzepatide, monitored by a licensed provider with real labs and real titration. Cash-pay, no subscription traps — telehealth across Utah.
GLP-1 medications work — but only with proper evaluation, baseline labs, and dose titration guided by a clinician. We do the medicine part right: candidacy assessment, monitoring, and a plan that protects muscle and addresses the root drivers of weight.
No auto-ship traps. Your provider adjusts your dose from how you respond.
Good candidates often have one or more of these goals.
Provider-prescribed and titrated to your response.
Dual-action option where appropriate.
We check the markers that matter before and during therapy.
Dose changes guided by results and tolerability — not a fixed schedule.
Protein, strength, and nutrition support alongside the medication.
No hidden subscription lock-ins.
Tell us a few basics. We text you within one business day to confirm a time and send your detailed intake form.
Your provider reviews your history and sends a lab order to LabCorp or Quest near you. Most labs return in 5–10 days.
Story, lab review, root-cause assessment, and a real care plan — all in one paid visit. You leave with a protocol.
Medications and supplements ship from licensed U.S. pharmacies. Provider check-in every 30–90 days.
GLP-1 care starts with the 30-minute targeted intake ($250): candidacy review, baseline labs, and your starting plan. Follow-ups are $175. Medication is billed separately by the pharmacy and varies by dose.
Compounded medications are prescribed at the discretion of the licensed provider and are not FDA-approved as compounded preparations. We review risks and candidacy with you before starting.
Many patients notice appetite changes within about two weeks; typical 90-day weight loss is often in the 15–25 lb range. Individual results vary and depend on evaluation and adherence.
No. We're cash-pay and transparent. You're not locked into an auto-ship contract.
GLP-1 care starts with the $250 Targeted Therapy Intake. We'll review your candidacy and labs, even if the answer is no.